downgrad neutral
non-econom behavior competitor econom consequ
infrastructur insight plenti pipelin china mexico latam infra
portola manag
america corp bac
model mainten ccar capac sustain averag return
back half pois acceler consum fire grill enjoy
model mainten ccar capac sustain averag return
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result
investor awar firm may conflict interest could affect object report investor consid report
singl factor make invest decis
assum coverag tp neutral rate largest retail
pharmaci health daili live destin europ walgreen previous
aspir low doubl digit adjust ep growth howev given on-going reimburs
pressur earlier year reduc lt ep growth target mid-to-high singl digit
outlook assum flat growth oper improv off-set return
incent comp payment reduc guidanc indic
expect show improv oper perform howev adjust ep
constant currenc expect broadli flat employe incent comp paid year
return next year beyond fiscal expect deliv sustain adjust ep growth
mid-to-high singl digit rang growth target base core busi grow
y/i share repurchas bln per year assum contribut
ep growth partli offset growth driver wba effect tax rate expect
increas creat annual headwind
basi point wba current growth algorithm take account variou test pilot
partnership cost perspect upsid contribut ventur assum
year period one partnership becom profit could upsid
estim hit exceed cost reduct target howev
save materi
transfer coverag ep estimate stock discount mani
headwind face howev look clear indic visibl earn
growth improv consid rais invest rate pt base
roughli ep estimate risk rate includ reduc tailwind off-set
reimburs pressur lower gener deflat lower brand inflat
date product utc date dissemin utc
downgrad neutral
rate outperform neutral
price month
ep cse street didnt stretch guidanc
math vs street gm increas in-lin street disappoint slightli
upsid average prior qtr sg de-lever wors consensu
delev said impress nke solid global revenue growth ex-fx
expect vs china vs
stock need view key posit ep revis nike
start deliv better sg leverag on-going solid revenue trend year
alreadi guid hsd rev ex-fx line lt algo gm
constrain fx invest rfid new manuf
asset year analyst day commit slight sg leverag
year average year sg delev guid flat/
slight leverag catch-up fx diminish help boost
sg leverag olymp horizon unclear us much flow-through
actual improv drive upsid guidanc bottom line nke long list initi
clearli deliv strong revenue growth everi region despit elev macro uncertainti key
debat pivot better cost contain drive stock higher near-
trim ep due increment fx sg invest larg
valuat tp base ep ebitda chang risk competit
date product utc date dissemin utc
price month
non-econom behavior competitor
lower target price conagra lower fy ep estim
view pullback share today bit overreact
remain sidelin regard outlook larg degre
compani miss expect reinforc concern articul januari
whether brand portfolio strong enough maintain momentum complic
effort turn around acquir pinnacl busi also difficult time reconcil
manag decis rais organ sale guidanc previous
look like need respond non-econom promot competitor sever brand
boyarde hunt mari callend time investor look
consum stapl compani de-risk outlook conagra appear increas risk
organ sale declin miss guidanc math oper profit
core busi declin prior year miss intern expect almost
manag attribut miss promot intens competitor manufactur
challeng recal duke peter pan chang unfavor wheat mill price
also hurt ardent mill jv pinnacl sale declin bit better expect
believ would adjust time ep miss
valuat target price base ev/ebitda multipl fy
estim valuat assum discount closest food peer line
averag discount inabl deliv synergi plan pose biggest risk valuat due
high degre financi leverag
date product utc date dissemin utc
price month
ep consensu pdco ep miss
estim stronger revenu off-set weaker profit also unveil initi
ep guidanc fall well short estim consensu
continu increment invest sale forc digit servic capabl enter
year two three year turnaround plan ep move reflect
temper albeit posit top-line experi continu margin degrad higher
price month
share sink bright spot print particularli double-digit
growth across core dental equip cad/cam respect anim health
experi initi guidanc call modest low mid-single-digit growth
continu margin degrad disappoint acknowledg remain
transit on-going initi strateg sourc privat label broader cost
manag time magnitud associ cost contribut remain elus still
share trade ebitda discount closest competitor
contribut outperform view risk demand competit landscap
date product utc date dissemin utc
portola manag
bottom line opportun host investor meet portola ceo scott
garland cfo mardi dier sheldon koenig well miller investor
relat manag team remain focus andexxa launch appear
enthusiast progress make well potenti market opportun
product given hospit admiss us annual due factor xa inhibitor-rel
bleed alreadi even greater adopt expect novel oral anti-coagul
noac go forward given advantag provid warfarin compani continu
comfort andexxa consensu forecast
team also excit cerdulatinib believ appreci given
encourag earli data ctcl follicular lymphoma
date product utc date dissemin utc
auy announc guidanc improv due jacobina lom refresh auy announc
revis near-term guidanc result review three-year lom plan note
updat guidanc reflect implement phase expans increas
current progress guidanc may benefit potenti
implant phase throughput increas upsid higher
grade ore target new miner resourc
phase expans drive improv near-term guidanc auy expect
produc jacobina origin guidanc better
cs estim cost guidanc slightli increas modestli
previou guidanc line cs estim
product guidanc also improv better cs estim
auy state sustain throughput rate expect implement
alreadi oper averag rate
higher miner resourc boost potenti higher product auy state follow
mill optim higher grade may potenti improv product without
grade boost auy alreadi expect produc current miner resourc
reserves/m resourc increas grade throughput potenti boost
product cs estim note updat reserv statement jacobina
declar time
guidanc improv slight posit modestli impress faster-than-
expect throughput improv jacobina highlight investor larg anticip
improv product result phase howev posit motiv
potenti improv grade jacobina look forward phase
date product utc date dissemin utc
america corp bac
model mainten ccar capac
close america announc ccar cycl capit planshar repurchas
authorization/dividend increas -- well publish expect gross share
repurchas versu cs estim capac evid last week dfast
result capac coupl manag determin return excess evid
ccar ask/author disclos eveningclearli posit much
factor full ccar author make chang model estim
would increas per share depend time price share repurchas
estim unchang off-set upsid higher capit return increas
conservat nim/nii expect increas confid achiev
estim sustain return forecast rotc stand rate
estim unchang estim unchang per share
base case estim risk/sensit driven first foremost pace econom
growth turn drive busi capit market activ well credit qualiti
price unchang appli weight averag valuat methodolog use
weight blue sky scenario weight base case scenario
weight gray sky scenario target price translat price forecast year-end
book valu p/tbv
date product utc date dissemin utc
price month
back half pois acceler consum
fire grill enjoy sun
mccormick ep beat estim due favor tax rate sale
growth miss despit miss downward revis ebit
guidanc stock demonstr remark resili major revis turn
relat technic differ compani account enterpris resourc
plan spend addit tepid result spice season appear transitori
larg stem impact late easter wet weather issu
rais ep estim account net benefit lower
tax rate partial off-set lower ebit relat erp classif
back half appear intact maintain sale forecast back half
year think slow start grill season econom slowdown china
materi impact result bigger pictur continu view well posit
capit strong demand trend spice season categori consum interest
adventur recip continu build
valuat target price assum price-to-earnings multipl estim
line consum stapl compani leadership posit attract nich
market church dwight acceler market share loss privat label
pose largest threat thesi
date product utc date dissemin utc
price month
model mainten ccar capac
close jpmorgan announc ccar cycl capit planshar repurchas
authorization/dividend increas -- well publish expect gross share
repurchas versu cs estim recal jpmorgan ran closer min point
took last week dfast result layer capit return expectationsclearli
imperfect exercis factor jpmorgan full ccar author make
chang model estim would increas per share depend time
price share repurchas estim unchang off-set upsid
higher capit return increas conservat nim/nii expect increas
confid achiev estim sustain return forecast rotc hold
even less/no nii growth rate share outperform
estim unchang per share respect base
case estim risk/sensit driven first foremost level econom activ
turn drive tradit bank busi capit market activ credit qualiti migrat
price unchang deriv via weight averag blue sky scenario
base case gray sky scenario translat forecast year-
date product utc date dissemin utc
price month
earlier week publish note reward outweigh risk highlight see
meaning near-term upsid refin macro continu improv week develop
data point give us convict construct refin call
end road pe philadelphia energi solut expect perman shut
oil refineri massiv fire caus substanti damag complex unit
expect go offlin earli next week earlier specul pe
might tri keep point breez side refineri run given extent
damag cost reconstruct pe decid mothbal refineri put complex
sale believ end road struggl asset even pe find
buyer come back storag termin pe padd refin
oper capac total us refin capac tighten east
coast product market also impli overal us refin util rise last
year peak posit independ refin
improv doe data crack week doe show gasolin draw
distil drew despit refin util hit view posit
week finish gasolin export drop earli april rebound
even posit distil export start
averag per latest doe report strong demand fundament domest
intern help repeal fear recess weigh sector padd
padd crack last day reflect tighter product fundament
pe downtim start show next doe els equal us weekli gasolin
product
import keep beta squeez mind high qualiti name
whose stock support high sharehold return howev strategi go long three
time use dk sourc fund neg
consequ diversifi refin earn
high refin leverag given capit disciplin best class manag team tag lowest
cost oper dividend support act defens pure beta rebound high
squeez name dk outperform big long
mid-cap name would gener neg return last week high beta
outperform lowest beta bp
date product utc date dissemin utc
earlier week part healthcar disrupt technolog innov seri
host boston bu tour small group investor visit iora health hq manag
attende includ rushika fernandopul co-found ceo dave field cfo tyler
man financ director adam fri manag fp
detail overview iora health busi model compani tidbit
pleas see note april redefin primari iora health stori narrat co-
founder/ceo cfo offer increment tidbit meet
iora redefin primari compani believ rebuild healthcar need
start bottom-up focu upon consum accord iora primari care
great place start upstream stress peopl eat move downstream
help peopl connect specialist iora work five six nation health plan iora
current doesnt work
great place adapt model mani dynam employ market
make difficult roughli iora growth medicar advantag mani larg
employ high churn employe iora health model typic take
year deliv result addit iora view challeng implement model
medicaid market due high level churn
financi futur target iora build de novo practic grow year term
patient volum end iora health plan practic number
current construct market across countri compani open three
big market year one houston tx two north carolina iora market iora
estim mln medicar live iora go practic phoenix
partnership built scratch iora close live market
opportun iora view cmmi direct contract demo program begin
excit futur opportun demo program allow progress provid group
contract directli compani also view opportun potenti chang law
around use hsa subscription-bas primari care chang stark law
date product utc date dissemin utc
rise rate cycl investor concern deposit beta
signific worri beta on-line bank would approach cumul
given market rate declin concern
on-line bank lower deposit cost rapidli enough sustain margin said
encourag on-line bank start cut rate time even ahead branch-bas bank
actual cut fed fund rate furthermor base last cycl deposit rate on-line
bank well whole industri continu fall even fed stop cut
believ on-line bank prudent manag deposit cost rate cut cycl
deposit price pressur abat industri level start come
on-line bank on-line bank move ahead industri cycl
far base industri data fdic deposit cost plateau across board
case yr cd actual come quarterli chang appear line
seen previou quarter save account deceler
deposit product money market cd relief deposit cost pressur also
observ specialti finance/onlin bank base websit note
deposit rate offer compani start come sinc second half
notabl cd even though fed fund rate cut yet initi concern
on-line bank might wait actual rate cut act compani cut
cd rate bp seen cut across board save rate
note lower save rate earlier week believ
bank follow cut affect entir base save deposit oppos cd
rate roll lower time
cumul deposit beta on-line bank decreas compar cumul deposit beta
period month apart adjust time fed rate chang
usual fallen somewher second half last month quarter cumul beta
rel price first rate hike decemb gener decreas
notic particularli june cd believ decreas save beta
begin soon follow recent move lower save rate
last cycl fed start lower rate industri start lower deposit rate
soon on-line bank react long branch-bas bank
look progress interest rate deposit cost last cycl
figur period deposit price action occur tandem rate move
time trend break product save cd figur
figur though deposit rate appear persist way deposit cost
may keep go fed fund rate stop downtrend
interest rate go stabil industri deposit cost less
persist thu stop go almost immedi see quarter lag
on-line bank seemingli respond quickli overal industri way note
on-line bank respond bit slower overal industri though cycl on-line
bank led far mention earlier last cycl whole industri lower deposit cost
magnitud rate cut averag on-line bank still cut
somewhat concern on-line bank would fixat market
share profit appear lead industri rate
fact lead ahead actual reduct asset yield strong
start lower part rate cycl
date product utc date dissemin utc
earlier week part healthcar disrupt technolog innov seri
host boston bu tour small group investor visit rxadvanc offic
administr offic nirali rana vice presid clinic solut liz thoma strategi
reimagin pbm solut servic rxadvanc found employ
innov strategi cloud-comput deep data analysi build collabor
pbm cloud platform enabl integr comprehens approach pharmaci
benefit manag rxadvanc manag believ platform enjoy lower oper
cost pbm effect reduc cost health plan sponsor compani
pharmaci benefit servic follow approach data-driven vs perception-cr enabl
reduct overal pharmaci cost reduct specialti cost
reduct avoid drug-impact medic cost
bln span beyond pbm servic rxadvanc see total address
market opportun bln bln pharmaci benefit servic bln
specialti servic bln account care servic compani also
process creat viabl busi financi model altern client look
creat intern pbm compani expect announc coalit partner
next four week anoth coalit partner announc week
partnership march made initi invest rxadvanc
current minor owner rxadvanc increas major ownership
posit rxadvanc also creat jv nirvanahealth
nirvanahealth solut rxadvanc see opportun reduc administr spend
transact process autom across enterpris unifi platform
compani see opportun reduc risk progress rate rate
optim opportun reduc avoid medic cost care deliveri
integr cost contain via value-bas contract provider/hospit risk share
date product utc date dissemin utc
closer look permian water midstream valu follow increas monet
discuss last year wrote water challeng requir persist invest
oper ensur oper continu current water asset increasingli view
potenti monet candid continu call capit disciplin make on-going
non-product invest less appeal depress valuat put pressur
manag team extract valu non- asset trade higher valuat
recent uptick water-rel midstream deal put ad focu topic provid
basi valu in-hous system oper ps ultim believ investor need
see cash door recogn hidden valu given water asset strateg
import compani also like sell minor stake bring partner offload
futur capital-expenditure burden pe activ evalu option first two
scale valu
estim water asset repres permian enterpris valu averag weve
receiv incom question water valuat given lack disclosur within provid
